Lexston Life Sciences Corp

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

—

Div yield, %

—

Shrs. gr., 5y

78.87%

Rev. gr., 5y

Revenues

Net income

-1m

L-10.88%

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Lexston Life Sciences Corp. functions as a biotechnology firm dedicated to providing analytical and research services for cannabis across Canada. Beyond general cannabis analysis, their comprehensive laboratory testing identifies pathogens and various toxins. Furthermore, the company is actively involved in pioneering methods for the standardized production and validation of plant-derived psychedelic compounds, specifically for applications in the mental health and wellness sector. The company's operations are based out of Vancouver, Canada.

URL

https://lexston.ca/

IPO date

Jun 25, 2021

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CAD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY
Title CAD in thousands, except ratios and share amounts	2026‑05	2025‑05	2024‑05	2023‑05	2022‑05	2021‑05	2020‑05
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT